AZ and Myriad conduct clinical trials for cancer
AstraZeneca PLC and Myriad Genetics (therapeutics and genetic testing for cancer, neurology, and infectious diseases) have teamed up to run clinical trials on AZ's compound for breast and ovarian cancer.
- In Vitro Diagnostics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- R&D (No Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.